The New York Yankees have a big decision to make this upcoming offseason when it comes to two-time All-Star Jazz Chisholm Jr. Chisholm is going to be a free agent after the season ...

Rookie campaign defined by rapid growth, the former lottery pick must now translate offseason conditioning into a high-stakes role within Utah’s evolving offensive system.

The Utah Jazz will be facing against Walker Kessler for the first time early next season.

The record-high Laker deal could lift the valuation of all NBA teams, including one of the worst teams in the league the past ...

Jazz Chisholm Jr. is facing backlash from New York Yankees fans for careless mistake during series against the Toronto Blue ...

New York Yankees second baseman Jazz Chisholm qualifies for free agency at the end of this Wold Series. If the Yankees don't ...

The Yankees keep waiting for Jazz Chisholm Jr. to take off. With 44 games left in the season, it has yet to actually happen.

Jazz Pharmaceuticals stock buys Actio Biosciences for $820 million to boost the KCNT1 epilepsy pipeline as Q2 2026 hits $1.2 ...

Aug 7, 2024; Bronx, New York, USA; New York Yankees third baseman Jazz Chisholm Jr. (13) reacts during the third inning against the Los Angeles Angels at Yankee Stadium. Mandatory Credit: Brad ...

Jazz Pharmaceuticals is paying up to $1.32 billion for a drug targeting a childhood epilepsy with no approved treatment. Here is the case and the risk.

Cyril Neville, of New Orleans' famed Neville Brothers, is bringing a bit of Big Easy funk to the Montclair Jazz Festival on ...

Jazz Pharmaceuticals, maker of the blockbuster epilepsy drug Epidiolex, is acquiring Actio Biosciences and its lead drug in ...